Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. (CYCN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CYCN · as of Jun 8, 2026
Key Statistics
Explore Cyclerion Therapeutics, Inc. Data
cycn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
cycn competitorsCYCN
ADXN
AIM
KTTA
NBY
PLRZStock Performance
Full HistoryAbout Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. operates as a biopharmaceutical company in the clinical development phase, concentrating on the discovery, advancement, and commercialization of therapeutic agents for deb…
what is cyclerion therapeutics, inc. · cycn stock overview · cyclerion therapeutics, inc. company profile · who is cyclerion therapeutics, inc. ceo · cycn NASDAQ · cyclerion therapeutics, inc. headquarters · cyclerion therapeutics, inc. business segments
About Stock Overview & Key Data
Cyclerion Therapeutics, Inc. (CYCN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 18, 2019. As of the latest trading session, CYCN stock price is $3.01, with a market capitalization of $13.0M. The stock has returned -4.46% over the past 12 months and +136.22% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Cyclerion Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cyclerion Therapeutics, Inc. reported revenue of $2.1M and net income of -$3.5M. For detailed data — including Cyclerion Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cyclerion Therapeutics, Inc. (CYCN) stock price is $3.01. The stock is traded on NASDAQ under the ticker symbol CYCN. The 52-week range is $1.03 – $8.48.